Elizabeth Jobes
Compliance Officer bei IMMUNOCORE HOLDINGS PLC
Vermögen: 183 412 $ am 30.04.2024
Profil
Elizabeth Varki Jobes is currently serving as the Treasurer & Director at Aegerion Pharmaceuticals, Inc., Independent Director at Ampio Pharmaceuticals, Inc., Independent Director at Blue Foundry Bancorp, Director at South Asian Bar Association of North America, Director at Eyam Vaccines & Immunotherapeutics Ltd., Director at Blue Foundry Bank, Global Chief Compliance Officer & Senior VP at Amryt Pharma Plc, and Vice President-Compliance at Immunocore Holdings Plc.
In the past, Ms. Jobes held positions such as Senior Director-Global Compliance at Cephalon, Inc., Director at Women's Way, Chief Compliance Officer & Vice President at Adolor Corp., Chief Compliance Officer & Senior Vice President at Auxilium Pharmaceuticals LLC, Chief-Repeat Violent Offenders Unit at City of Philadelphia (Pennsylvania), Chief Compliance Officer-North America & SVP at EMD Serono, Inc., and Global Chief Compliance Officer & Legal Counsel at Spark Therapeutics, Inc. She also served as the Global Chief Compliance Officer & Senior VP at Amryt Pharma Holdings Ltd.Ms. Jobes completed her undergraduate studies at The Pennsylvania State University and obtained her graduate degree from Rutgers Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BLUE FOUNDRY BANCORP
0,09% | 02.01.2024 | 21 502 ( 0,09% ) | 183 412 $ | 30.04.2024 |
| 15.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Elizabeth Jobes
| Unternehmen | Position | Beginn |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
| AMPIO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.02.2022 |
| AMRYT PHARMA PLC | Compliance Officer | 01.01.2020 |
| BLUE FOUNDRY BANCORP | Direktor/Vorstandsmitglied | 05.01.2023 |
| IMMUNOCORE HOLDINGS PLC | Compliance Officer | 01.01.2024 |
| South Asian Bar Association of North America | Direktor/Vorstandsmitglied | - |
| Eyam Vaccines & Immunotherapeutics Ltd. | Direktor/Vorstandsmitglied | 01.10.2021 |
Blue Foundry Bank
 Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | Direktor/Vorstandsmitglied | 01.01.2023 |
Ehemalige bekannte Positionen von Elizabeth Jobes
| Unternehmen | Position | Ende |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Compliance Officer | 01.01.2020 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ | ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von Elizabeth Jobes
| The Pennsylvania State University | Undergraduate Degree |
| Rutgers Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMPIO PHARMACEUTICALS, INC. | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private Unternehmen | 14 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
| City of Philadelphia (Pennsylvania) | Government |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Women's Way
 Women's Way Investment Trusts/Mutual FundsMiscellaneous Women''s Way is a non-profit organization, which committed to gender equality and justice. The company is headquartered in Philadelphia, PA. | Miscellaneous |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | Finance |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
| Blue Foundry Bancorp | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
| South Asian Bar Association of North America | |
| Eyam Vaccines & Immunotherapeutics Ltd. |
